# Effects of Antipsychotics on Brain Insulin Action in Females

> **NCT06251635** · NA · RECRUITING · sponsor: **Centre for Addiction and Mental Health** · enrollment: 15 (estimated)

## Conditions studied

- Insulin Resistance
- Menstrual Cycle
- Type 2 Diabetes
- Antipsychotics

## Interventions

- **DRUG:** Olanzapine 2.5Mg Oral Tablet
- **DRUG:** Placebo
- **DRUG:** Insulin Lispro 100 UNT/ML
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT06251635
- **Lead sponsor:** Centre for Addiction and Mental Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-03
- **Primary completion:** 2026-08-01
- **Final completion:** 2026-08-01
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2026-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06251635

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06251635, "Effects of Antipsychotics on Brain Insulin Action in Females". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06251635. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*